$290 Million is the total value of Artia Global Partners LP's 34 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMGN | New | IMMUNOGEN INC | $10,253,165 | – | 543,358 | +100.0% | 3.53% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $9,377,834 | – | 102,940 | +100.0% | 3.23% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $8,836,592 | – | 77,162 | +100.0% | 3.05% | – |
| ETNB | New | 89BIO INC | $8,820,562 | – | 465,465 | +100.0% | 3.04% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $6,312,757 | – | 87,848 | +100.0% | 2.18% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $3,102,831 | – | 112,340 | +100.0% | 1.07% | – |
| PLRX | New | PLIANT THERAPEUTICS INC | $1,812,000 | – | 100,000 | +100.0% | 0.62% | – |
| BMEA | New | BIOMEA FUSION INC | $558,671 | – | 25,452 | +100.0% | 0.19% | – |
| MOR | New | MORPHOSYS AGsponsored ads | $324,938 | – | 43,499 | +100.0% | 0.11% | – |
| GRTS | New | GRITSTONE BIO INC | $185,582 | – | 95,170 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVO-NORDISK A S | 4 | Q3 2023 | 25.8% |
| MERCK & CO INC | 4 | Q3 2023 | 14.1% |
| ARGENX SE | 4 | Q3 2023 | 12.3% |
| LILLY ELI & CO | 4 | Q3 2023 | 14.5% |
| ABBVIE INC | 4 | Q3 2023 | 5.6% |
| ASTRAZENECA PLC | 4 | Q3 2023 | 5.4% |
| SEAGEN INC | 4 | Q3 2023 | 4.5% |
| BIOMARIN PHARMACEUTICAL INC | 4 | Q3 2023 | 4.3% |
| NEUROCRINE BIOSCIENCES INC | 4 | Q3 2023 | 2.1% |
| VERTEX PHARMACEUTICALS INC | 4 | Q3 2023 | 2.6% |
View Artia Global Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Artia Global Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.